Abstract:Magnesium oxide (MgO) nanoparticles were green synthesized using mahua (Madhuca longifolia) flower extracts by solvent evaporation and characterized by UV-visible spectroscopy, X-ray diffraction analysis (XRD), Fourier transform infrared spectroscopy (FTIR), Field emission scanning electron microscopy (FESEM), and Energy dispersive X-ray analysis (EDX). The drug loading of sumatriptan succinate (SS), an anti-migraine drug, was optimized using MINITAB's response surface methodology (RSM) Box Behnken model (BBD) model. The investigation of drug adsorption and release kinetics was further conducted using the optimized set obtained through RSM. The optimized parameters consisted of 23.53 mg of nanoparticles, a loading time of 6 h, and a pH of 9, yielding the experimental drug loading efficiency ~47%. The primary objective of this study is to investigate the potential of utilizing these green synthesized MgO nanoparticles for a dual purpose. The primary objective of this study is to investigate the viability of utilizing MgO nanoparticles synthesized through green route for the delivery of an anti-migraine medication. Additionally, the study aims to examine the degradation of these nanoparticles at physiological pH levels, with the intention of potentially enhancing cellular absorption. The investigation involved the assessment of drug release kinetics using various mathematical models, with a focus on the release of SS from MgO nanoparticles. This evaluation was conducted at different pH levels, specifically pH 5, 7, and 9. It has been found that the SS release increases as pH decreases, which is attributed to the dissolution of MgO nanoparticles, which therefore exhibits varied behavior at different pHs. The confirmation of the degradation of the green synthesized MgO nanoparticles was achieved through the execution of a degradation study, followed by the analysis of the obtained samples using FESEM and EDS. At neutral, the release data obtained adhered to the Higuchi model, which suggests that the release of the drug is based on diffusion. This finding is particularly advantageous for the controlled release of an anti-migraine drug. The results obtained from the study indicate that MgO nanoparticles have the potential to serve as a significant component in drug delivery systems, specifically as drug carriers. Attachment of SS over MgO nanoparticles to form SS loaded MgO nanoparticles and its possible working mechanism.

In Situ Thermosensitive Mucoadhesive Nasal Gel Containing Sumatriptan: In Vitro and Ex Vivo Evaluations

Quality by design for sumatriptan loaded nano-ethosomal mucoadhesive gel for the therapeutic management of nitroglycerin induced migraine

Formulation and development of frovatriptan succinate in situ gel for nasal drug delivery: In vitro and ex vivo evaluation

Formulation development and evaluation of nasal in situ gel of promethazine hydrochloride

Compritol-Based Nanostrucutured Lipid Carriers (NLCs) for Augmentation of Zolmitriptan Bioavailability via the Transdermal Route: In Vitro Optimization, Ex Vivo Permeation, In Vivo Pharmacokinetic Study

Formulation of Intranasal Mucoadhesive Thermotriggered In Situ Gel Containing Mirtazapine as an Antidepressant Drug

Hydrophilic nasal gel of lidocaine hydrochloride. 1st Communication: Preparation, formulation optimization and in vitro release study.

In Vivo Evaluation of Almotriptan malate Formulation through Intranasal Route for the Treatment of Migraine: Systematic Development and Pharmacokinetic Assessment

PLGA Nanoparticles Based Mucoadhesive Nasal In Situ Gel for Enhanced Brain Delivery of Topiramate

Quality by Design Approach for Preparation of Zolmitriptan/Chitosan Nanostructured Lipid Carrier Particles - Formulation and Pharmacodynamic Assessment

Development of in vitro and in vivo evaluation of mucoadhesive in-situ gel for intranasal delivery of vinpocetine

Frovatriptan succinate intranasal delivery for brain targeting – in vivo study.‎

Surface thermodynamics of mucoadhesive dry powder formulation of zolmitriptan

Optimization for formulation of Zhi Xiong San thermo-sensitive gel by central composite design-response surface method and study on characterization of its nasal mucosal permeability

Optimization of Pramipexole-Loaded In Situ Thermosensitive Intranasal Gel for Parkinson's Disease

Preclinical evaluation of dual action intranasal formulation intended for postoperative/cancer associated therapies

Mucoadhesive in situ nasal gel of amoxicillin trihydrate for improved local delivery: Ex vivo mucosal permeation and retention studies

Synergistic action of sumatriptan delivery and targeting magnesium deficiency using green, pH-responsive MgO nanoparticles synthesized from mahua flower extracts

Preparation, characterization, and in vivo pharmacokinetics of thermosensitive in situ nasal gel of donepezil hydrochloride

Preparation and in vitro characterization of thermosensitive and mucoadhesive hydrogels for nasal delivery of phenylephrine hydrochloride

In situ gel based on gellan gum as new carrier for nasal administration of mometasone furoate.